Drug Notebook

Drug Info Tools
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Licensed from
pyridoxine
Page: 1 2 Next >

Uses

Pyridoxine Deficiency

Treatment of vitamin B6 deficiency.

Dietary Requirements

Adequate intake needed to prevent vitamin B6 deficiency.

Adequate intake of pyridoxine can be accomplished through consumption of fortified ready-to-eat cereals; meals containing substantial portions of meat, fish, or poultry; white potatoes and other starchy vegetable; and noncitrus fruits.

Recommended Dietary Allowance (RDA) in adults based on a plasma pyridoxal phosphate concentration of 5 ng/mL.

Adequate intake (AI) established for infants ≤6 months of age based on observed mean vitamin B6 intake of infants fed principally human milk; AI for infants 7–12 months of age based on AI for younger infants and data in adults.

RDA for children 1–18 years of age based on data in adults.

Pyridoxine-dependent Seizures

Treatment of pyridoxine-dependent seizures.

Metabolic Disorders

Xanthurenic aciduria, cystathioninuria, and homocystinuria resulting from genetic abnormalities may respond to high doses of pyridoxine.

Prevention or Treatment of Drug-induced Neurotoxicity

Prevent or treat neuropathy in patients receiving isoniazid. Pyridoxine prophylaxis recommended in isoniazid-treated individuals with nutritional deficiency (e.g., meat and milk-deficient diet), diabetes mellitus, HIV infection, renal failure, alcoholism, and in exclusively breast-fed infants, pregnant women, and lactating women.

Also has been used to prevent or treat neurotoxic adverse effects (e.g., peripheral neuropathy) associated with ethionamide or capecitabine.

Adjunct for treatment of acute toxicity resulting from isoniazid overdosage.

Mushroom Toxicity

Adjunct for treatment of acute toxicity caused by mushrooms† of the genus Gyromitra. Used to correct marked neurologic effects (e.g., seizures, coma) induced by methylhydrazine (produced by hydrolysis of the toxins in these mushrooms).

Dosage and Administration

Administration

Usually administered orally. May be administered by IM, IV, or sub-Q injection when oral administration is not feasible.

Dosage

Available as pyridoxine hydrochloride; dosage expressed in terms of pyridoxine hydrochloride.

Pediatric Patients

Dietary and Replacement Requirements

Oral

Infants ≤6 months of age: Recommended AI is 0.1 mg (0.01 mg/kg) daily.

Infants 7–12 months of age: Recommended AI is 0.3 mg (0.03 mg/kg) daily.

Children 1–3 years of age: RDA is 0.5 mg daily.

Children 4–8 years of age: RDA is 0.6 mg daily.

Children 9–13 years of age: RDA is 1 mg of daily.

Boys 14–18 years of age: RDA is 1.3 mg daily.

Girls 14–18 years of age: RDA is 1.2 mg daily.

Pyridoxine-dependent Seizures

Oral

Maintenance following parenteral administration: 2–100 mg daily has been recommended.

IM or IV

10–100 mg has been recommended. Follow with lifelong oral pyridoxine.

Adults

Pyridoxine Deficiency

Oral

2.5–10 mg daily.

After clinical signs of deficiency are corrected, administer a multivitamin preparation containing 2–5 mg of pyridoxine hydrochloride once daily for several weeks.

IM or IV

10–20 mg daily for 3 weeks.

Follow with a multivitamin preparation containing 2–5 mg of pyridoxine hydrochloride once daily for several weeks.

Dietary and Replacement Requirements

Oral

Men and women 19–50 years of age: RDA is 1.3 mg daily.

Men ≥51 years of age: RDA is 1.7 mg daily.

Women ≥51 years of age: RDA is 1.5 mg daily.

Prevention of Drug-induced Neurotoxicity

Oral

CDC recommends 25 mg daily for certain isoniazid-treated patients.

Isoniazid Overdose

IV followed by IM

Ingestion of >10 g of isoniazid: Dose of pyridoxine hydrochloride equals the amount of isoniazid ingested.

Initially, 4 g IV; followed by 1 g IM every 30 minutes until the entire dose has been given.

Mushroom Toxicity

IV

25 mg/kg infused over 15–30 minutes and repeated as necessary to control effects up to a maximum cumulative dose of 15–20 g daily has been suggested.†

Prescribing Limits

Adults

Long-term (> 2 months) administration of large dosages (≥ 2 g daily) can cause sensory neuropathy or neuronopathy syndromes.

Special Populations

Pregnant Women

RDA for pregnant women is 1.9 mg daily.

Lactating Women

RDA for lactating women is 2 mg daily.Requirements increased in lactating women to ensure adequate concentration of the vitamin in milk (130 ng/mL).

Page: 1 2 Next >
Advertisement
Back to Top